MENU

GLUE Monte Rosa Therapeutics Forecast, Technical & Fundamental Analysis

Monte Rosa Therapeutics Inc is a clinical-stage biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins... Show more

GLUE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
GLUE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

GLUE is expected to report earnings to fall 15.40% to -36 cents per share on November 05

Monte Rosa Therapeutics GLUE Stock Earnings Reports
Q3'26
Est.
$-0.36
Q2'26
Missed
by $0.05
Q1'26
Missed
by $0.03
Q4'25
Missed
by $0.10
Q3'25
Beat
by $0.03
The last earnings report on August 06 showed earnings per share of -43 cents, missing the estimate of -37 cents. With 420.08K shares outstanding, the current market capitalization sits at 1.00B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
321 Harrison Avenue
Phone
+1 617 949-2643
Employees
150
Web
https://www.monterosatx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BLRX2.590.06
+2.37%
BioLineRx Ltd
FNWD43.240.98
+2.32%
Finward Bancorp
CNK37.770.79
+2.14%
Cinemark Holdings
BBDC8.670.05
+0.58%
Barings BDC
ABEV2.91N/A
N/A
Ambev SA

GLUE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GLUE has been loosely correlated with RVMD. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if GLUE jumps, then RVMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLUE
1D Price
Change %
GLUE100%
+0.43%
RVMD - GLUE
42%
Loosely correlated
+2.56%
KPTI - GLUE
39%
Loosely correlated
-6.36%
KURA - GLUE
39%
Loosely correlated
-0.92%
AXON - GLUE
38%
Loosely correlated
-3.35%
XNCR - GLUE
38%
Loosely correlated
-0.34%
More
Monte Rosa Therapeutics (GLUE) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com